Tezobell (Bortezomib)
Model: Lyophilized powder for injection (in vial)
Category: Pharmaceutical
Exhibitor: CKD OTTO PHARMACEUTICALS
Booth No: M625
Characteristic
Strength : 3.5 mg
Dosage form : Lyophilized powder for injection
Indication : Breast Cancer, NSCLC, Prostate cancer, etc
1. The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy
2. The treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.
Storage Condition :
When reconstituted as directed, Bortezomib may be stored at 25°C. Reconstituted Bortezomib should be administered immediately or may be stored for 8 hours under indoor lighting.
Unopened vials may be stored at below 30°C. Shelf life 24 months.
Other Products
Products you may be interested in
Highest Rated Products